Geniposide prevents tumor growth by inhibiting colonic interleukin-1β and monocyte chemoattractant protein-1 via down-regulated expression of cyclooxygenase-2 and thymocyte selection-associated high mobility box proteins TOX/TOX2 in azoxymethane/dextran sulfate sodium-treated mice
International Immunopharmacology · 2023-05 · 118 · 110077
DOI: 10.1016/j.intimp.2023.110077 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-05. Verfasst von Yoshiyuki Kimura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Biomedicine, Ehime University Graduate School of Medicine, Japan; Department of Natural Product Science, Faculty of Pharmace…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Colitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Ehime University, Japan Society for the Promotion of Science.
Themen: Mobilisation
Abstract (Originalsprache)
Colon cancer was the second leading cause of cancer-related deaths in Japan in 2019. The effects of geniposide isolated from Gardenia jasminoides fructus (Rubiaceae) on the azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced growth of colon tumors and changes in interleukin (IL)-1 β, monocyte chemoattractant protein (MCP)-1, IL-10, and programmed cell death-1 (PD-1) levels in the colon were investigated. The intraperitoneal administration of AOM (10 mg/kg) on days 0 and 27 induced colorectal carcinogenesis. Free access to 1% (w/v) DSS drinking water was given to mice on days 7-15, 32-33, and 35-38. Geniposide (30 and 100 mg/kg) was orally administered on days 1-16, discontinued for 11 days (days 16 to 26), and then administered again on days 27-41. Colonic levels of cytokines, chemokine, and PD-1 were measured using by enzyme-linked immunosorbent assay (ELISA). Increases in colorectal tumor numbers and areas were significantly inhibited by geniposide. In addition, geniposide (100 mg/kg) reduced colonic levels of IL-1 β, MCP-1, PD-1 and IL-10 by 67.4, 57.2, 100%, and 100% respectively. Cyclooxygenase (COX)-2- and thymocyte selection high mobility group box proteins (TOX/TOX2)-positive cell numbers were significantly reduced by geniposide. Geniposide (30 and 100 mg/kg) decreased the phosphorylation of signal transducer and activator of transcription 3 (STAT3) expressions in immunohistochemical analysis by 64.2 and 98.2%, respectively. Thus, the inhibitory effects of geniposide on colon tumor growth may be associated with reductions in the colonic levels of IL-1 β, MCP-1, IL-10, and PD-1 via the down-regulated expression of COX-2 and TOX/TOX2 through the inhibition of Phospho-STAT3 expression (in vivo and in vitro).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Functional Biomedicine, Ehime University Graduate School of Medicine, Japan; Department of Natural Product Science, Faculty of Pharmaceutical Sciences, Osaka Medical and Pharmacology University, Nasahara,…
- Division of Functional Histology, Department of Functional Biomedicine, Ehime University Graduate School of Medicine, Japan.
- Department of Natural Product Science, Faculty of Pharmaceutical Sciences, Osaka Medical and Pharmacology University, Nasahara, Takatsuki City, Osaka 569-1094, Japan.
Förderung
- Ehime University
- Japan Society for the Promotion of Science
Zitieren
APA
Kimura, Y., Sumiyoshi, M., & Taniguchi, M. (2023). Geniposide prevents tumor growth by inhibiting colonic interleukin-1β and monocyte chemoattractant protein-1 via down-regulated expression of cyclooxygenase-2 and thymocyte selection-associated high mobility box proteins TOX/TOX2 in azoxymethane/dextran sulfate sodium-treated mice. International Immunopharmacology, 118, 110077. https://doi.org/10.1016/j.intimp.2023.110077
Vancouver
Kimura Y, Sumiyoshi M, Taniguchi M. Geniposide prevents tumor growth by inhibiting colonic interleukin-1β and monocyte chemoattractant protein-1 via down-regulated expression of cyclooxygenase-2 and thymocyte selection-associated high mobility box proteins TOX/TOX2 in azoxymethane/dextran sulfate sodium-treated mice. International Immunopharmacology. 2023;118:110077. doi:10.1016/j.intimp.2023.110077
BibTeX
@article{Kimura2023,
author = {Kimura, Yoshiyuki and Sumiyoshi, Maho and Taniguchi, Masahiko},
title = {Geniposide prevents tumor growth by inhibiting colonic interleukin-1β and monocyte chemoattractant protein-1 via down-regulated expression of cyclooxygenase-2 and thymocyte selection-associated high mobility box proteins TOX/TOX2 in azoxymethane/dextran sulfate sodium-treated mice},
journal = {International Immunopharmacology},
year = {2023},
volume = {118},
pages = {110077},
doi = {10.1016/j.intimp.2023.110077}
}
EUVIMED